Meet Michael Hennig at DDC 2022 in San Diego

leadXpro’s CEO Michael Hennig will present at the Drug Discovery Chemistry meeting 2022 in San Diego (and online)

He will describe how biophysical methods including CGI (grating coupled interferometry) are instrumental for the success of structure biology based projects, delivering affinity, stoichiometry and kinetic information on binding. 

Case studies of small molecule-GPCR (e.g. CCR2, A2B) and -ion channel (e.g. TRPV4) interaction studies as well as binding studies of synthetic nanobodies raised against membrane protein targets will be presented.